Combined HIV prevention, the New York City Condom Distribution Program, and the evolution of safer sex behavior among persons who inject drugs in New York City

AIDS and Behavior

Volumn 18, Issue 3, 2014, Pages 443-451

  Des Jarlais, D C ^a   Arasteh, K ^a   McKnight, C ^a   Feelemyer, J ^a   Hagan, H ^b   Cooper, H L F ^c   Perlman, D C ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Combined prevention; Condom condom promotion; Harm reduction; Heterosexual transmission; HIV; Persons who inject drugs

Indexed keywords

ADULT; ARTICLE; CONDOM; DISEASE TRANSMISSION; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; INTERVIEW; MALE; MIDDLE AGED; PROGRAM EVALUATION; SAFE SEX; SEXUAL BEHAVIOR; SEXUALITY; SOCIOECONOMICS; STATISTICS; SUBSTANCE ABUSE; UNITED STATES; UTILIZATION REVIEW; VIROLOGY;

ADULT; CONDOMS; FEMALE; HIV INFECTIONS; HUMANS; INTERVENTION STUDIES; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEW YORK CITY; PROGRAM EVALUATION; RISK-TAKING; SAFE SEX; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84896402728     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0664-0     Document Type: Article

References (34)

1. World Health Organization UNODC, Joint United Nations Programme on HIV/AIDS. Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: 2008.
2. Sendziuk P. Harm reduction and HIV-prevention among injecting drug users in Australia: an international comparison. Can Bull Med Hist/Bulletin canadien d'histoire de la médecine. 2007;24(1):113-29.
3. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376(9737):285- 301.
4. Van den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007;102(9):1454-62.
5. de Vos AS, van der Helm JJ, Prins M, Kretzschmar MEE. Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam: evidence for harm reduction? Paper presented at: International AIDS Conference 2012; Washington D.C.
6. Des Jarlais DC, Arasteh K, McKnight C, et al. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend. 2010;109(1):154-60.
7. Montaner J, Lima VD, Yip B, Day I, et al. Expanded HAART coverage is associated with decreased HIV/AIDS morbidity and HIV new diagnoses: an update on the 'treatment as prevention' experience in British Columbia, Canada. Paper presented at: International AIDS Conference 2012; Washington D.C.
8. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357(9266):1397-401.
9. Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80(4):iii7-14.
10. Des Jarlais DC, Arasteh K, McKnight C, et al. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. Drug Alcohol Depend. 2010;109(1-3):154-60.
11. Newman RG, Cates MS. Methadone treatment in narcotic addiction: program management, findings, and prospects for the future. New York: Academic Press; 1977.
12. Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95(8):1439-44.
13. Heller D, Paone D. Access to sterile syringes for injecting drug users in New York City: politics and perception (1984-2010). Subst Use Misuse. 2011;46(2-3):140-9.
14. Des Jarlais DC, Arasteh K, Friedman SR. HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Subst Use Misuse. 2011;46(2-3):131-9.
15. Henman AR, Paone D, Des Jarlais DC, Kochems LM, Friedman SR. Injection drug users as social actors: a stigmatized community's participation in the syringe exchange programmes of New York City. AIDS Care. 1998;10(4):397-408.
16. Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007;97(1):117-24.
17. Deren S, Hagan H, Friedman S, et al. Current and emerging research needs in studying the NYC HIV-drug use epidemic. Subst Use Misuse. 2011;46(2-3):316-9.
18. Lert F, Kazatchkine MD. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview. Int J Drug Policy. 2007;18(4):255-61.
19. New York City Department of Health and Mental Hygiene. HIV Surveillance & Epidemiology Program - HIV/AIDS Annual Surveillance Statistics. New York City: NYCDOHMH;1982-2013.
20. Chiasson MA, Berenson L, Li W, et al. Declining HIV/AIDS mortality in New York city. JAIDS. 1999;21(1):59-64.
21. Messeri P, Lee G, Abramson DM, Aidala A, Chiasson MA, Jessop DJ. Antiretroviral therapy and declining AIDS mortality in New York City. Med Care. 2003;41(4):512-21.
22. Wong T, Chiasson M, Reggy A, Simonds R, Heffess J, Loo V. Antiretroviral therapy and declining AIDS mortality in New York City. J Urban Health. 2000;77:492-500.
23. Burke RC, Wilson J, Bernstein KT, et al. The NYC Condom: use and acceptability of New York City's branded condom. Am J Public Health. 2009;99(12):2178-80.
24. Burke RC, Wilson J, Kowalski A, et al. NYC Condom use and satisfaction and demand for alternative condom products in New York City sexually transmitted disease clinics. J Urban Health. 2011;88(4):749-58.
25. Des Jarlais DC, McKnight CM, Arasteh K, et al. Use of the "NYC Condom" among people who use drugs. J Urban Health. (in press).
26. Des Jarlais DC, Friedman SR, Novick DM, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989;261(7):1008-12.
27. Des Jarlais DC, Arasteh K, Hagan H, McKnight C, Perlman DC, Friedman SR. Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am J Public Health. 2009;99(S2):S445-51.
28. Des Jarlais DC, Perlis T, Arasteh K, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS. 2005;19:S20-5.
29. Stata 12 [computer program]. College Station, Texas 2012.
30. Des Jarlais DC, Bramson HA, Wong C, et al. Racial/ethnic disparities in HIV infection among people who inject drugs: an international systematic review and meta-analysis. Addiction. 2012;107(12):2087-95.
31. Parsons JT, Schrimshaw EW, Wolitski RJ, et al. Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation. AIDS. 2005;19:S13-25.
32. MacKellar DA, Hou SI, Whalen CC, et al. HIV/AIDS complacency and HIV infection among young men who have sex with men, and the race-specific influence of underlying HAART beliefs. Sex Transm Dis. 2011;38(8):755-63.
33. Des Jarlais DC, Perlis T, Friedman SR, et al. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health. 1998;88(12):1801-6.
34. Des Jarlais DC, Perlis T, Arasteh K, et al. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. JAIDS. 2004;35(2):158-66.